Karydas Daphne
Insider CIK 1816952 · SNDX Chief Financial Officer · LOGC Director · CMPS Director · MLYS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-09-15 | 2026-09-17 | 3,000 | — | $0 | 35,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-09-15 | 2026-09-17 | 3,000 | $28.58 | $85.7K | 6,200 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-09-15 | 2026-09-17 | 3,000 | $12.02 | $36.1K | 9,200 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-09-15 | 2026-09-17 | 3,000 | — | $0 | 35,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-09-15 | 2026-09-17 | 3,000 | $28.58 | $85.7K | 6,200 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-09-15 | 2026-09-17 | 3,000 | $12.02 | $36.1K | 9,200 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-06-17 | 2026-06-17 | 3,000 | — | $0 | 38,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-06-17 | 2026-06-17 | 3,000 | $25.00 | $75.0K | 6,200 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-06-17 | 2026-06-17 | 3,000 | $12.02 | $36.1K | 9,200 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2026-05-27 | 2026-05-29 | 21,110 | — | $0 | 21,110 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-03-31 | 2026-04-02 | 3,000 | — | $0 | 41,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-03-31 | 2026-04-02 | 3,000 | $25.00 | $75.0K | 6,200 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-03-31 | 2026-04-02 | 3,000 | $12.02 | $36.1K | 9,200 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-02-19 | 2026-02-20 | 8,300 | — | $0 | 8,300 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-02-19 | 2026-02-20 | 6,200 | — | $0 | 6,200 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-11-13 | 2025-11-13 | 15,000 | — | $0 | 17,900 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-11-13 | 2025-11-13 | 15,000 | $10.20 | $153.0K | 15,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-13 | 2025-11-13 | 10,115 | $45.81 | $463.4K | 4,885 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-13 | 2025-11-13 | 4,885 | $46.36 | $226.5K | 0 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2025-06-12 | 2025-06-13 | 26,000 | — | $0 | 26,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2025-02-13 | 2025-02-24 | 32,900 | — | $0 | 32,900 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2024-05-22 | 2024-05-23 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2024-05-09 | 2024-05-13 | 26,000 | — | $0 | 26,000 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2023-09-18 | 2023-09-20 | 52,000 | — | $0 | 52,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-09-13 | 2023-09-14 | 44,000 | — | $0 | 44,000 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | D To issuer deriv | 2022-11-16 | 2022-11-17 | 12,500 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2022-06-17 | 2022-07-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2021-06-11 | 2021-06-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2021-02-03 | 2021-02-05 | 95,000 | — | $0 | 95,000 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2020-12-10 | 2020-12-14 | 20,000 | — | $0 | 20,000 | SEC↗ |